ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	33/236	191/7206	1.40248450106e-15
ko05340	Primary immunodeficiency	14/236	30/7206	1.01694114766e-13
ko04650	Natural killer cell mediated cytotoxicity	21/236	97/7206	2.9818995428e-12
ko04659	Th17 cell differentiation	19/236	106/7206	1.05799132226e-09
ko05152	Tuberculosis	25/236	187/7206	1.48569546327e-09
ko05330	Allograft rejection	10/236	24/7206	1.53993232312e-09
ko05140	Leishmaniasis	16/236	75/7206	1.61308137015e-09
ko04612	Antigen processing and presentation	16/236	77/7206	2.43260881929e-09
ko05145	Toxoplasmosis	20/236	126/7206	3.50421630434e-09
ko05164	Influenza A	23/236	167/7206	3.90438241933e-09
ko05162	Measles	19/236	120/7206	9.16937021933e-09
ko04380	Osteoclast differentiation	20/236	134/7206	1.05019268967e-08
ko05320	Autoimmune thyroid disease	10/236	29/7206	1.36106056593e-08
ko05321	Inflammatory bowel disease (IBD)	13/236	56/7206	1.93955470018e-08
ko05332	Graft-versus-host disease	8/236	18/7206	3.8771224002e-08
ko05168	Herpes simplex infection	22/236	182/7206	9.69832736708e-08
ko04640	Hematopoietic cell lineage	13/236	64/7206	1.0676843907e-07
ko04145	Phagosome	19/236	162/7206	1.20631492826e-06
ko05150	Staphylococcus aureus infection	9/236	36/7206	1.61805040895e-06
ko04672	Intestinal immune network for IgA production	9/236	37/7206	2.0777527119e-06
ko04062	Chemokine signaling pathway	21/236	201/7206	2.21287727605e-06
ko04658	Th1 and Th2 cell differentiation	14/236	96/7206	2.43443776749e-06
ko04620	Toll-like receptor signaling pathway	14/236	100/7206	4.00022968099e-06
ko04940	Type I diabetes mellitus	8/236	32/7206	6.25873409995e-06
ko05310	Asthma	6/236	17/7206	1.05842731542e-05
ko04064	NF-kappa B signaling pathway	13/236	96/7206	1.29187258366e-05
ko05133	Pertussis	12/236	87/7206	2.31459496125e-05
ko04660	T cell receptor signaling pathway	14/236	124/7206	4.892792189e-05
ko03050	Proteasome	9/236	54/7206	5.46285783045e-05
ko05144	Malaria	8/236	45/7206	8.87483206601e-05
ko04630	Jak-STAT signaling pathway	14/236	132/7206	9.75747484198e-05
ko04621	NOD-like receptor signaling pathway	15/236	157/7206	0.000180980955495
ko05416	Viral myocarditis	8/236	55/7206	0.000378024556216
ko05167	Kaposi's sarcoma-associated herpesvirus infection	16/236	191/7206	0.00049973884588
ko04662	B cell receptor signaling pathway	10/236	88/7206	0.000562307549313
ko04666	Fc gamma R-mediated phagocytosis	12/236	122/7206	0.000615472407802
ko05323	Rheumatoid arthritis	10/236	89/7206	0.0006156364877
ko04217	Necroptosis	15/236	178/7206	0.00070188763589
ko04610	Complement and coagulation cascades	9/236	79/7206	0.00103841415896
ko04514	Cell adhesion molecules (CAMs)	12/236	130/7206	0.00108500947594
ko05161	Hepatitis B	14/236	173/7206	0.00155701537327
ko05142	Chagas disease (American trypanosomiasis)	11/236	130/7206	0.00345905456176
ko04664	Fc epsilon RI signaling pathway	8/236	77/7206	0.00352351143412
ko00120	Primary bile acid biosynthesis	4/236	20/7206	0.00359264927033
ko04622	RIG-I-like receptor signaling pathway	7/236	62/7206	0.00392010176986
ko05132	Salmonella infection	9/236	98/7206	0.00464155731399
ko00590	Arachidonic acid metabolism	6/236	52/7206	0.00668438927253
ko04360	Axon guidance	1/236	233/7206	0.00742279360896
ko04611	Platelet activation	12/236	163/7206	0.0112012500048
ko05146	Amoebiasis	8/236	99/7206	0.0155469217543
ko00592	alpha-Linolenic acid metabolism	3/236	19/7206	0.0228046320033
ko04144	Endocytosis	19/236	342/7206	0.0272352636249
ko05206	MicroRNAs in cancer	1/236	177/7206	0.0314720481526
ko04310	Wnt signaling pathway	1/236	181/7206	0.0317834310477
ko04670	Leukocyte transendothelial migration	10/236	151/7206	0.0323804989071
ko05160	Hepatitis C	10/236	153/7206	0.0341396022127
ko04072	Phospholipase D signaling pathway	12/236	197/7206	0.0381942894937
ko05166	HTLV-I infection	16/236	292/7206	0.0416589402025
ko05224	Breast cancer	1/236	174/7206	0.0473373851218
ko05016	Huntington's disease	2/236	215/7206	0.0493860287126